Estrogen receptors in gastric cancer:Advances and perspectives

被引:9
作者
Muhammad Saif Ur Rahman [1 ]
Jiang Cao [1 ]
机构
[1] Clinical Research Center, The Second Affiliated Hospital, Zhejiang University School of Medicine
基金
中国国家自然科学基金;
关键词
Gastric cancer; Estrogen receptor; Isoform; Carcinogenesis; Mechanism; Genomic pathway; Nongenomic pathway;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100214 ;
摘要
Worldwide, gastric cancer is one of the most common malignancies with high mortality. Various aspects of thedevelopment and progression of gastric cancer continue to be extensively investigated in order to further our understanding and provide more effective means for the prevention, diagnosis, and treatment of the disease. Estrogen receptors(ERs) are steroid hormone receptors that regulate cellular activities in many physiological and pathological processes in different tissues. There are two distinct forms of ERs, namely ERα and ERβ, with several alternative-splicing isoforms for each. They show distinct tissue distribution patterns and exert different biological functions. Dysregulation of ERs has been found to be associated closely with many diseases, including cancer. A number of studies have been conducted to investigate the role of ERs in gastric cancer, the possible mechanisms underlying these roles, and the clinical relevance of deregulated ERs in gastric cancer patients. To date, inconsistent associations of different ERs with gastric cancer have been reported. These inconsistencies may be caused by variations in in vitro cell models and clinical samples, including assay conditions and protocols with regard to different forms of ERs. Given the potential of the deregulated ERs as diagnostic/prognostic markers or therapeutic targets for gastric cancer, it will be important to identify/confirm the association of each ER isoform with gastric cancer, to determine the specific roles and interactions that these individual ER isoforms play under specific conditions in the development and/or progression of gastric cancer, and to elucidate precisely these mechanisms. In this review, we summarize the achievements from early ER studies in gastric cancer to the most up-to-date discoveries, with an effort to provide a comprehensive understanding of the role of ERs roles in gastric cancer and its possible mechanisms. Furthermore, we propose directions for future investigations.
引用
收藏
页码:2475 / 2482
页数:8
相关论文
共 31 条
[1]  
Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues[J]. Xin-Han Zhao Shan-Zhi Gu Shan-Xi Liu Department of Medical 0neology,First Hospital of Xi’an Jiaotong University,Xi’an 710061,Shaanxi Province,China Bo-Rong Pan Department of Oncology,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,Shaanxi Province,China.World Journal of Gastroenterology. 2003(04)
[2]  
Global cancer statistics, 2012[J] . Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet‐Tieulent,Ahmedin Jemal.CA: A Cancer Journal for Clinicians . 2015 (2)
[3]   Involvement of the Akt signaling pathway in ER-α36/GRP94-mediated signaling in gastric cancer [J].
Fu, Zhengqi ;
Zhen, Hongyan ;
Zou, Feng ;
Wang, Xuming ;
Chen, Ying ;
Liu, Lijiang .
ONCOLOGY LETTERS, 2014, 8 (05) :2077-2080
[4]  
Molecular Pathways: Estrogen Pathway in Colorectal Cancer[J] . Afsaneh Barzi,Annika Medea Lenz,Melissa J. Labonte,Heinz-Josef Lenz.Clinical Cancer Research . 2013 (21)
[5]   Involvement of ER-α36 in the malignant growth of gastric carcinoma cells is associated with GRP94 overexpression [J].
Fu, Zhengqi ;
Deng, Hao ;
Wang, Xuming ;
Yang, Xiuping ;
Wang, Zhaoyi ;
Liu, Lijiang .
HISTOPATHOLOGY, 2013, 63 (03) :325-333
[6]   ER-α36-mediated gastric cancer cell proliferation via the c-Src pathway [J].
Wang, Xuming ;
Deng, Hao ;
Zou, Feng ;
Fu, Zhenqi ;
Chen, Ying ;
Wang, Zhaoyi ;
Liu, Lijiang .
ONCOLOGY LETTERS, 2013, 6 (02) :329-335
[7]   Overexpression of ERα inhibits proliferation and invasion of MKN28 gastric cancer cells by suppressing β-catenin [J].
Zhou, Jichun ;
Teng, Rongyue ;
Xu, Chaoyang ;
Wang, Qinchuan ;
Guo, Jufeng ;
Xu, Chenpu ;
Li, Ziduo ;
Xie, Shuduo ;
Shen, Jianguo ;
Wang, Linbo .
ONCOLOGY REPORTS, 2013, 30 (04) :1622-1630
[8]  
Treatment with bisphenol A and methoxychlor results in the growth ofhuman breast cancer cells and alteration of the expression of cell cycle-relatedgenes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway[J] . Hye-Rim Lee,Kyung-A Hwang,Min-Ah Park,Bo-Rim Yi,Eui-Bae Jeung,Kyung-Chul Choi.International Journal of Molecular Medicine . 2012 (5)
[9]  
Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogensignaling of ER-negative breast cancer cells[J] . Xin-Tian Zhang,Ling Ding,Lian-Guo Kang,Zhao-Yi Wang.Oncology Reports . 2012 (6)
[10]   Expression of estrogen receptors in gastric cancer and their clinical significance [J].
Ryu, Woo-Sang ;
Kim, Jong-Han ;
Jang, You-Jin ;
Park, Sung-Soo ;
Um, Jun-Won ;
Park, Seong-Heum ;
Kim, Seung-Joo ;
Mok, Young-Jae ;
Kim, Chong-Suk .
JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (04) :456-461